Essential Partners’s Unicycive Therapeutics UNCY Stock Holding History

Essential Partners’s Portfolio UNCY Stock Details UNCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66	Buy	+14	New	+$73	﹤0.01%	2741

Other funds holding UNCY

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners's UNCY Position: Q3 2026 in Review

Essential Partners opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 14 shares worth $66. The stake represents ﹤0.01% of the portfolio and ranks #2741 among its holdings.

9 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

Essential Partners held 14 shares of Unicycive Therapeutics worth $66 as of Q3 2026.
Unicycive Therapeutics was a new Essential Partners position in Q3 2026.
Unicycive Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2741 holding.
9 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.